Healthcare Magazine February 2018 | Page 13

also helps to educate OB-GYNs and general practitioners who may never had to counsel someone on genetic mutations before .
The plan is to roll the scheme out worldwide , but the challenge is to get local doctors fully trained in genetic counselling . “[ In the ] UK there ’ s already a lot of genetic counselling availability , but there are definitely countries where there ’ s a lot to do , where there ’ s zero local genetic counselling . That ’ s going be an important aspect of our growth , in terms of how we bridge that gap for different geographies .” Laraki believes that the UK is likely to become one of the world leaders in doing this population level prevention , where he says “ there ’ s definitely a lot of forward thinking .”
The future “ I do think it is literally the highest ROI investment that is available in healthcare , for both wealthy countries like the UK and the US , as well as developing countries ,” Laraki says . “ If you look at a country like Nigeria , 180mn people have 40 oncologists , that ’ s less oncologists than in London . There needs to be a big investment on the treatment side , but I think there

“ I do think it is literally the highest ROI investment that is available in healthcare , for both wealthy countries like the UK and the US , as well as developing countries ”

OTHMAN LARAKI Co-founder and CEO of Color
might be an interesting effect where similarly to how a lot of developing countries leapfrogged from landlines directly to cellphones , I wonder whether we might see something similar on the prevention side .
“ For every late stage cancer you prevent , you can provide genetics and early detection for 1,000 people from the beginning . It ’ s going be interesting to see the broad adoption in countries like the UK and the US . I think in the next few years there ’ ll be true population level precision prevention , but it might also happen in developing countries in a similar time frame .”
13